X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2024/04/24/2868259/0/en/Pharming-to-be-honored-as-Industry-Innovator-at-National-Organization-for-Rare-Disorders-NORD-2024-Rare-Impact-Awards.html
https://www.globenewswire.com/news-release/2024/04/08/2858868/0/en/Pharming-announces-completion-of-enrollment-in-pediatric-clinical-trial-of-leniolisib.html
https://www.globenewswire.com//news-release/2023/12/13/2795234/0/en/Pharming-Group-announces-development-plans-for-leniolisib-for-additional-primary-immunodeficiencies-PIDs.html
https://www.globenewswire.com//news-release/2023/12/13/2795234/0/en/Pharming-Group-announces-development-plans-for-leniolisib-for-additional-primary-immunodeficiencies-PIDs.html
https://www.globenewswire.com//news-release/2023/11/21/2783690/0/en/Pharming-announces-first-patient-dosed-in-pediatric-clinical-trial-for-children-aged-1-to-6-years-for-leniolisib.html
https://www.globenewswire.com//news-release/2023/11/10/2778337/0/en/Pharming-Group-provides-updates-on-EMA-regulatory-review-of-leniolisib-MAA-and-plans-to-file-for-UK-regulatory-approval.html
https://www.prnewswire.com/news-releases/pharming-announces-first-patient-enrolled-in-phase-iii-clinical-trial-of-leniolisib-for-the-treatment-of-apds-in-japan-301896457.html
https://www.contractpharma.com/contents/view_breaking-news/2023-03-27/pharming-receives-fda-approval-of-joenja/?widget=listSection
https://www.rttnews.com/3352431/pharming-stock-reaps-significant-gains-after-landmark-fda-approval.aspx
https://www.prnewswire.com/news-releases/pharming-announces-first-patient-enrolled-in-pediatric-clinical-trial-of-leniolisib-301750968.html
https://www.prnewswire.com/news-releases/pharming-announces-positive-interim-analysis-data-from-open-label-extension-study-of-leniolisib-in-presentation-at-the-64th-american-society-of-hematology-ash-annual-meeting-and-exposition-301703186.html
https://www.prnewswire.com/news-releases/pharming-announces-european-medicines-agency-ema-validates-its-marketing-authorisation-application-under-accelerated-assessment-for-leniolisib-301661947.html
https://www.prnewswire.com/news-releases/pharming-announces-european-medicines-agency-ema-validates-its-marketing-authorisation-application-under-accelerated-assessment-for-leniolisib-301661943.html
https://pharmaphorum.com/news/pharming-files-rare-disease-drug-leniolisib-in-europe/
https://www.prnewswire.com/news-releases/pharming-submits-a-marketing-authorisation-application-to-the-european-medicines-agency-for-leniolisib-301645354.html
https://www.pharmtech.com/view/ec-grants-orphan-drug-designation-to-pharming-s-leniolisib
http://www.pharmatimes.com/news/pharmings_apds_drug_scores_eu_orphan_status_1354585
https://www.pharmiweb.com/press-release/2020-10-21/pharming-receives-orphan-drug-designation-from-the-european-commission-for-leniolisib-for-the-treatm
Market Place
Share 
